TGFB1 and renal fibrosis: Thus, sympathetic overactivation facilitates EMT of renal epithelial cells and fibrosis via the α1-adrenoceptor driven TGF-β signaling mechanism, inhibition of which by an α1-adrenoceptor antagonist provides a promising approach for the treatment of renal fibrosis (Fig. 3).